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Abstract Glutathione peroxidase 1 (GPX1) is a
ubiquitously expressed selenium-dependent enzyme
that protects cells against oxidative damage by
reducing hydrogen peroxide and a wide range of
organic peroxides. Some epidemiological studies
have correlated low GPX activity or particular
GPX1 polymorphisms with enhanced risk of
cancer, although these correlations have not been
consistently observed in all populations. Therefore,
we conducted the present study to evaluate the
possible association of GPX1 Pro198Leu polymor-
phism and erythrocyte GPX activity with the risk of
developing prostate cancer and to clarify whether
erythrocyte GPX activity levels were correlated with
the GPX1 Pro198Leu genotype in the Macedonian
population. The GPX1 Pro198Leu genotype was
determined in 82 prostate cancer cases and 123
control individuals. We found an overall protective
effect of the variant Leu allele of the GPX1
polymorphism on the prostate cancer risk. Hetero-
zygous carriers of the variant Leu allele had a
significantly lower risk of prostate cancer compared
with homozygous wild-type individuals (OR, 0.38;
95% CI, 0.20–0.75; P = 0.004). Erythrocyte GPX
activity was analyzed in 73 cases and 91 controls.
The erythrocyte GPX activity in the cancer group
was lower than in the healthy controls. Additionally,
we compared the erythrocyte GPX activity in the
control group of 90 subjects and found no significant
differences by genotype. These findings suggest that
individual susceptibility of prostate cancer may be
modulated by GPX1 polymorphism and that the
combination of genetic factors involved in oxidative
response with environmental carcinogens may play
an important role in prostate carcinogenesis.
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